Commonly prescribed oral anti-obesity medication and alternative anorectics

2Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the “golden bullet”. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the “fen-phen” prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.

Cite

CITATION STYLE

APA

Baker, J. S., Davies, B., & Graham, M. R. (2016). Commonly prescribed oral anti-obesity medication and alternative anorectics. In Chemically Modified Bodies: The Use of Diverse Substances for Appearance Enhancement (pp. 173–199). Palgrave Macmillan. https://doi.org/10.1057/978-1-137-53535-1_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free